Sort
130,381 grants matching “hiv”
Role of Viral Reservoirs in the Pathogenesis of HIV Disease
$920,008Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
HIV PREVENTION AND CARE SERVICES FOR YOUNG PEOPLE IN KENYA
$920,000Malinda Wheeler · Hope Cote D'Ivoire · U62 · FY2008 · PS
Role of innate immunity in HIV related vascular disease: biomarkers & mechanisms
$919,962Robert C Kaplan · Albert Einstein College Of Medicine · R01 · FY2014 · HL
RECONSTITUTION OF CMV IMMUNITY IN HIV-INFECTED HOSTS
$919,938Fred Hutchinson Cancer Research Center · R01 · FY2001 · AI
Clinical Studies of Interactions Between HIV and Malaria
$919,923Diane V Havlir · University Of California, San Francisco · U01 · FY2006 · AI
The Grady Center for Health Disparities
$919,878Emory University · P60 · FY2004 · MD
Safeguard the Household
$919,750Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · U19 · FY2009 · AI
IMPROVING COMBINED BUPRENORPHINE-BEHAVIORAL TREATMENT
$919,722University Of Vermont &St Agric College · R01 · FY2003 · DA
Helping Families Reduce HIV in African American Youth
$919,695University Of Pennsylvania · R01 · FY2002 · MH
Administrative Core
$919,649Susan Little · University Of California, San Diego · P01 · FY2011 · AI
Mechanism of Action of Novel Dual Acting Pyrimidinediones
$919,455Robert Walter Buckheit · Imquest Biosciences · R44 · FY2010 · AI
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
$919,441Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
PORPHYRINS AS MICROBICIDES FOR PREVENTION OF STDS/HIV
$919,412Emory University · P01 · FY2001 · AI
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
$919,323Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
PRECLINICAL GAP-FILLING SERVICES: STUDIES TO ASSESS INTERACTIONS BETWEEN DAPIVIRINE AND VAGINALLY-APPLIED, OVER-THE-COUNTER PRODUCTS
$919,179Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2018 · AI
GHESKIO HIV Clinical Trial Unit
$919,160Jean William Pape · Gheskio Center · UM1 · FY2015 · AI
Acceptable Multi-user Biodegradable Extended Release (AMBER) Implant System for HIV Prevention
$919,111Leah Johnson · Research Triangle Institute · R01 · FY2024 · AI
Novel Concepts for the Eradication of HIV
$919,050Rafick-Pierre Sekaly · Vgti Florida · DP1 · FY2010 · DA
Dissecting Polyclonal Sera to Reveal Correlates of Productive Immune Responses to HIV
$919,034Andrew Barrett Ward · Scripps Research Institute, The · R01 · FY2018 · AI
AN HIV INTERVENTION FOR FATHERS AND THEIR SONS
$919,028Emory University · R01 · FY2000 · MH
Linking Churches with Parks to Increase Physical Activity Among Latinos
$918,987Kathryn Pitkin Derose · Rand Corporation · R01 · FY2020 · CA
Repurposing of Macrolide Antibiotic Clarithromycin for the Prevention of Lung and Breast Cancer
$918,981Powel Brown · University Of Tx Md Anderson Can Ctr · N01 · FY2019 · CA
The HIV Reservoir
$918,847Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
T Cell Immune Responses To HIV And Other Pathogens
$918,847Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: NHP Purchase and Holding
$918,721Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2019 · AI